Clinical applications of mesenchymal stem cells
1Laboratory of Immune Regulation, Convergent Research Consortium for Immunologic Disease, Seoul, Korea.
The Korean Journal of Internal Medicine
|July 19, 2013
Summary
Mesenchymal stem cells (MSCs) show therapeutic potential due to their differentiation and immune-modulating abilities. Clinical trials are investigating MSCs for various diseases, including cancer and autoimmune disorders, highlighting their broad applicability.
Area of Science:
- Stem cell biology
- Immunology
- Regenerative medicine
Background:
- Mesenchymal stem cells (MSCs) are multipotent progenitor cells with self-renewal and multilineage differentiation capabilities.
- MSCs exhibit immunomodulatory and anti-inflammatory properties, migrating to inflammation sites and interacting with immune cells.
- Their accessibility and expansion potential position MSCs as a promising therapeutic tool for diverse conditions.
Purpose of the Study:
- To review the current clinical applications of MSCs.
- To evaluate the efficacy and limitations of MSCs in ongoing clinical trials.
- To explore the potential of genetically modified MSCs in cancer therapy.
Main Methods:
- Review of reported clinical trials involving MSCs.
- Analysis of MSC efficacy in treating various diseases.
- Discussion of MSC limitations and future prospects.
Main Results:
- MSCs are being investigated in clinical trials for orthopedic injuries, graft-versus-host disease, cardiovascular diseases, autoimmune diseases, and liver diseases.
- Genetically modified MSCs show promise for anticancer therapy.
- The efficacy and limitations of MSCs in these trials are under active investigation.
Conclusions:
- MSCs possess significant therapeutic potential owing to their regenerative and immunomodulatory functions.
- Clinical applications of MSCs span a wide range of conditions, with ongoing research focusing on optimizing their use.
- Further research is necessary to fully understand and overcome the limitations of MSC-based therapies.
Related Concept Videos
01:19Mesenchymal Stem Cells
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:17Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
01:19Clinical Applications of Epidermal Stem Cells
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...